The use of enzymopathic human red cells in the study of malarial parasite glucose metabolism
- PMID: 2833958
The use of enzymopathic human red cells in the study of malarial parasite glucose metabolism
Abstract
The in vitro growth of Plasmodium falciparum malaria parasites was assayed in mutant red cells deficient in either diphosphoglycerate mutase (DPGM) or phosphoglycerate kinase (PGK). In addition, cDNA probes developed for human DNA sequences coding for these enzymes were used to examine the parasite genome by means of restriction endonuclease digestion and Southern blot analysis of parasite DNA. In both types of enzymopathic red cells, parasite growth was normal. In infected DPGM deficient red cells, no DPGM activity could be detected, and in normal red cells, DPGM activity declined slightly in a manner suggestive of parasite catabolism of host protein. However, in infected PGK deficient red cells, there was a 100-fold increase in PGK activity, and in normal red cells, a threefold increase in PGK activity was observed. Parasite PGK could be recovered from isolated parasites, and a marked increase in heat instability of parasite PGK as compared with the host cell enzyme was noted. Neither cDNA probe was found to cross-react with DNA sequences in the parasite genome. It is concluded that the parasite has no requirement for DPGM, and probably has no gene for this enzyme. On the other hand, the parasite does require PGK, (an adenosine triphosphate [ATP] generating enzyme) and synthesizes its own enzyme, which must have been encoded in the parasite genome. The parasite PGK gene most likely lacks sufficient homology to be detected by a human cDNA probe. Enzymopathic red cells are useful tools for elucidating the glycolytic enzymology of parasites and their co-evolution with their human hosts.
Similar articles
-
A study on the complexes between human erythrocyte enzymes participating in the conversions of 1,3-diphosphoglycerate.Arch Biochem Biophys. 1997 Sep 15;345(2):185-92. doi: 10.1006/abbi.1997.0222. Arch Biochem Biophys. 1997. PMID: 9308888
-
Study of a kindred with partial deficiency of red cell 2,3-diphosphoglycerate mutase (2,3-DPGM) and compensated hemolysis.Blood. 1978 Jun;51(6):1107-16. Blood. 1978. PMID: 148301
-
Plasmodium falciparum: identification and purification of the phosphoglycerate kinase of the malaria parasite.Exp Parasitol. 1992 Aug;75(1):10-8. doi: 10.1016/0014-4894(92)90117-s. Exp Parasitol. 1992. PMID: 1639156
-
Plasmodium falciparum carbohydrate metabolism: a connection between host cell and parasite.Blood Cells. 1990;16(2-3):453-60; discussion 461-6. Blood Cells. 1990. PMID: 2257322 Review.
-
Red cell glycolytic enzyme disorders caused by mutations: an update.Cardiovasc Hematol Disord Drug Targets. 2009 Jun;9(2):95-106. doi: 10.2174/187152909788488636. Cardiovasc Hematol Disord Drug Targets. 2009. PMID: 19519368 Review.
Cited by
-
A Bioinformatics Approach for Homology Modeling and Binding Site Identification of Triosephosphate Isomerase from Plasmodium falciparum 3D7.J Young Pharm. 2012 Oct;4(4):261-6. doi: 10.4103/0975-1483.104370. J Young Pharm. 2012. PMID: 23492818 Free PMC article.
-
Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro.Front Cell Infect Microbiol. 2022 Mar 15;12:840968. doi: 10.3389/fcimb.2022.840968. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35372095 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources